2. Academic Validation
  3. 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents

2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents

  • Int J Mol Sci. 2019 Dec 29;21(1):234. doi: 10.3390/ijms21010234.
B Pajak 1,  E Siwiak 1,  M Sołtyka 1,  A Priebe 2,  R Zieliński 3,  I Fokt 3,  M Ziemniak 4,  A Jaśkiewicz 1,  R Borowski 1,  T Domoradzki 1,  W Priebe 3
Affiliations

Affiliations

  • 1 Independent Laboratory of Genetic and Molecular Biology, Kaczkowski Military Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland.
  • 2 Texas Oncology, Division of Gynecologic Oncology, 910 E. Houston Street, Tyler, TX 75702, USA.
  • 3 Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Rd., Houston, TX 77054, USA.
  • 4 Biological and Chemical Research Centre, Department of Chemistry, University of Warsaw, 02-089 Warsaw, Poland.
PMID: 31905745 DOI: 10.3390/ijms21010234
Abstract

The ability of 2-deoxy-d-glucose (2-DG) to interfere with d-glucose metabolism demonstrates that nutrient and energy deprivation is an efficient tool to suppress Cancer cell growth and survival. Acting as a d-glucose mimic, 2-DG inhibits glycolysis due to formation and intracellular accumulation of 2-deoxy-d-glucose-6-phosphate (2-DG6P), inhibiting the function of Hexokinase and glucose-6-phosphate isomerase, and inducing cell death. In addition to glycolysis inhibition, other molecular processes are also affected by 2-DG. Attempts to improve 2-DG's drug-like properties, its role as a potential adjuvant for other chemotherapeutics, and novel 2-DG analogs as promising new Anticancer agents are discussed in this review.

Keywords

2-DG analogs; 2-deoxy-d-glucose; anticancer therapy; glioblastoma.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z